Quince Therapeutics
QNCX
QNCX
35 hedge funds and large institutions have $9.55M invested in Quince Therapeutics in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
6% more funds holding
Funds holding: 33 → 35 (+2)
0.39% less ownership
Funds ownership: 12% → 11.61% (-0.39%)
Holders
35
Holding in Top 10
–
Calls
$1.76M
Puts
$7K
Top Buyers
| 1 | +$196K | |
| 2 | +$170K | |
| 3 | +$167K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$136K |
| 5 |
State Street
Boston,
Massachusetts
|
+$128K |
Top Sellers
| 1 | -$297K | |
| 2 | -$290K | |
| 3 | -$83.1K | |
| 4 |
IP
Intellectus Partners
San Francisco,
California
|
-$41.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$25.3K |